Evidence map›Paper›PMID 29151960›Full record

ArticleJournal of Cancer2017

R.E.N.A.L. Nephrometry Score: A Preoperative Risk Factor Predicting the Fuhrman Grade of Clear-Cell Renal Carcinoma.

Shao-Hao Chen, Yu-Peng Wu, Xiao-Dong Li, Tian Lin, Qing-Yong Guo, Ye-Hui Chen, Jin-Bei Huang, Yong Wei, Xue-Yi Xue, Qing-Shui Zheng and 1 more

Abstract read
In one paragraph

Article in Journal of Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shao-Hao ChenDepartment of Urology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Yu-Peng WuDepartment of Urology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Xiao-Dong LiDepartment of Urology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Tian LinDepartment of Urology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Qing-Yong GuoDepartment of Urology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Ye-Hui ChenDepartment of Urology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Jin-Bei HuangDepartment of Urology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Yong WeiDepartment of Urology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Xue-Yi XueDepartment of Urology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Qing-Shui ZhengDepartment of Urology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Ning XuDepartment of Urology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clear-cell renal carcinomafuhrman gradepredicting.the R.E.N.A.L score

Identifiers

PMID29151960
PMCPMC5688926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.